HF2930 (Legislative Session 94 (2025-2026))
Amyotrophic lateral sclerosis research funding provided, report required, appropriation cancelled, and money appropriated.
Related bill: SF3155
AI Generated Summary
Purpose of the Bill
The bill aims to support research into amyotrophic lateral sclerosis (ALS) by reallocating funds through the University of Minnesota to partner with the Mayo Clinic for further study. It seeks to build on past appropriations to improve ALS research outcomes and ultimately find a cure for the disease.
Main Provisions
Cancellation of Previous Appropriations: The bill cancels $15 million previously allocated to the Office of Higher Education for ALS research under past laws.
New Funding Allocation: In fiscal year 2026, $15 million is appropriated from the general fund to the University of Minnesota's Board of Regents to collaborate with the Mayo Clinic on ongoing ALS research. This is a one-time appropriation with funds available until June 30, 2029.
Annual Reporting Requirement: Starting January 15, 2026, and continuing annually until January 15, 2030, or until all funds are used, the University of Minnesota must report to the legislature on how these funds are being utilized in the partnership for ALS research.
Significant Changes to Existing Law
Repeal of Previous Legislation: The bill repeals the sections of previous laws that outlined specific appropriations and grant distribution for ALS research through the Office of Higher Education.
Shift in Research Administration: The focus shifts from the Office of Higher Education administering competitive grants to a direct partnership model between the University of Minnesota and the Mayo Clinic.
Relevant Terms
- ALS (Amyotrophic Lateral Sclerosis)
- University of Minnesota
- Mayo Clinic
- Appropriation
- Higher Education
- Research Funding
- Legislative Reporting
- Repeal
Bill text versions
- Introduction PDF file
Past committee meetings
- Higher Education Finance and Policy on: April 03, 2025 13:00
Actions
Date | Chamber | Where | Type | Name | Committee Name |
---|---|---|---|---|---|
March 26, 2025 | House | Floor | Action | Introduction and first reading, referred to | Higher Education Finance and Policy |
Citations
[ { "analysis": { "added": [], "removed": [], "summary": "This section modifies unencumbered balance policies for ALS research appropriations under section 16A.28.", "modified": [ "Includes new provisions for ALS research appropriations not canceling until a later date." ] }, "citation": "16A.28", "subdivision": "" }, { "analysis": { "added": [], "removed": [], "summary": "This section removes the limit on administrative cost coverage for ALS-related grants under section 16B.98, subdivision 14.", "modified": [ "Allows for additional use of appropriated funds for administrative costs beyond the usual statutory limit." ] }, "citation": "16B.98", "subdivision": "subdivision 14" } ]